Capsugel prepares to explore sale or IPO: Reuters

Capsugel, a U.S. maker of capsule products and other drug delivery systems, is preparing to explore a sale or initial public offering that could value it at more than $5 billion including debt, Reuters News reported.

23 March 2016•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles